DRL launches Renvela generic in US, price target at Rs 2200: HDFC Securities News News / News 7 years ago 524 Views comments The pharma major Dr Reddys Laboratories (DRL) has launched kidney disease drug Renvela generic in the US market. How big an opportunity can this be fo... Read more
News South Delhi Municipal Corporation distributes air purifiers to four schools News / News - 6 years ago
News Overwweight on HDFC, LIC Housing Finance; like Gruh Finance: Sanjiv Bhasin News / News - 7 years ago
Comments